Darktrace
ExitedA leader in enterprise immune system technology
Darktrace has raised €200M across 5 funding rounds from 11 investors, most recently a Series D+ round in Sep 2018. Based in Cambridge, UK; founded 2013; active in Cybersecurity. Acquired by Thoma Bravo in 2024. Data as of 28 Oct 2026.
Total raised
€200M
€199,777,645
Funding rounds
5
Investors
11
distinct backers
Active since
2015-03
latest 2018-09
Funding by year
EUR raised per yearDarktrace — funding by year — interactive chart.
Data table
| Darktrace — funding by year | |
|---|---|
| 2015 | €36M |
| 2016 | €58M |
| 2017 | €63M |
| 2018 | €42M |
Funding rounds
5 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2018-09-26 | Series D+ | €42M | 1011 Ventures,KKR,Vitruvian Partners | View deal → |
| 2017-09-05 | Series D+ | €63M | Insight Partners,KKR & Co. (Kohlberg Kravis Roberts & Co.),Summit Partners,Ten Eleven Ventures | View deal → |
| 2016-07-01 | Series C | €58M | Hoxton Ventures,KKR,SoftBank,Summit Partners,Ten Eleven Ventures | View deal → |
| 2015-07-01 | Series B | €20M | Summit Partners | View deal → |
| 2015-03-01 | Series A | €16M | Hoxton Ventures,Invoke Capital Partners,Talis Capital | View deal → |
Exit
Type
acquisition
Date
Apr 2024
Value
—
Acquiror
Thoma Bravo (United States of America)
Investors
11Acquisitions
2- Cado Security2025
- Cybersprint2022 · €48M
Related news
Similar companies
same sector or countryGlobal coverage: FundingData